Another population of β4+ tumor cells with the EpCam+panCK+N-cadherin-E-cadherin+ phenotype prevailed in patients with liver metastases (40.87 (5.01; 76.92), p = 0.0018) and in patients without metastases (26.17 (0; 88.71)%, p = 0.0019) compared with patients with lung metastases (5.42 (0–8.08)%) (Figure 3B). Here, EPCAM is linked to neoplasm.